Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis
Abstract The aim of this study was to assess the prevalence of cardiovascular risk factors in TAK, to describe the use of aspirin and statins and the risk factors associated with vascular ischemic complications and relapses. We conducted a retrospective study on TAK patients diagnosed between 2010 a...
Guardado en:
Autores principales: | Charlotte Laurent, Sergio Prieto-González, Pierre Belnou, Fabrice Carrat, Olivier Fain, Azeddine Dellal, Maria C. Cid, José Hernández-Rodríguez, Arsène Mekinian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c38fe663bfbe493b8453eccfb5a6f005 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Takayasu arteritis: Prevalence and clinical presentation in Switzerland.
por: Andrea D Gloor, et al.
Publicado: (2021) -
Intracranial Involvement in Takayasu’s Arteritis
por: Andrea Johnson, et al.
Publicado: (2021) -
Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Anne Claire Desbois, et al.
Publicado: (2021) -
Takayasu Arteritis – A Systematic Review
por: Hrisrova D., et al.
Publicado: (2019) -
Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis
por: Jayanthi Peter, et al.
Publicado: (2010)